We are live on ! Find out more
VA

Verdad Advisers Portfolio holdings

AUM $88.8M
This Fund
S&P 500
This Quarter Est. Return
+13.25%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$88.8M
AUM Growth
+$1.45M
Cap. Flow
-$2.06M
Cap. Flow %
-2.32%
Top 10 Hldgs %
21.25%
Holding
237
New
133
Increased
18
Reduced
23
Closed
58

Sector Composition

1 Healthcare 41.87%
2 Technology 13.22%
3 Financials 10.56%
4 Consumer Discretionary 7.94%
5 Communication Services 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
26
Chevron
CVX
$373B
$936K 1.05%
4,525
-13,983
-76% -$2.55M
AMN icon
27
AMN Healthcare
AMN
$1.36B
$917K 1.03%
50,000
+5,000
+11% +$95.1K
TALK icon
28
Talkspace
TALK
$873M
$908K 1.02%
+175,551
New +$777K
CRI icon
29
Carter's
CRI
$1.4B
$894K 1.01%
25,000
+5,000
+25% +$182K
NGL icon
30
NGL Energy Partners
NGL
$1.89B
$863K 0.97%
+70,000
New +$795K
MOMO
31
Hello Group
MOMO
$886M
$860K 0.97%
149,253
+40,036
+37% +$259K
ATAI icon
32
AtaiBeckley Inc
ATAI
$2.66B
$806K 0.91%
+227,670
New +$857K
AII
33
American Integrity Insurance
AII
$366M
$792K 0.89%
41,095
+3,555
+9% +$67.7K
FHI icon
34
Federated Hermes
FHI
$4.46B
$777K 0.88%
+13,710
New +$751K
ACRS icon
35
Aclaris Therapeutics
ACRS
$793M
$739K 0.83%
+197,042
New +$665K
DNTH icon
36
Dianthus Therapeutics
DNTH
$5.77B
$730K 0.82%
+8,699
New +$504K
VSNT
37
Versant Media Group
VSNT
$5.08B
$703K 0.79%
+18,997
New +$640K
TERN
38
DELISTED
Terns Pharmaceuticals
TERN
$701K 0.79%
+13,301
New +$546K
SVRA icon
39
Savara
SVRA
$1.13B
$701K 0.79%
+128,376
New +$715K
HRTG icon
40
Heritage Insurance Holdings
HRTG
$819M
$695K 0.78%
26,494
-2,280
-8% -$60.2K
GM icon
41
General Motors
GM
$68.6B
$686K 0.77%
9,207
-6,623
-42% -$527K
MRK icon
42
Merck
MRK
$315B
$681K 0.77%
5,660
-5,986
-51% -$691K
DECK icon
43
Deckers Outdoor
DECK
$14.8B
$671K 0.76%
+6,708
New +$719K
PRG icon
44
PROG Holdings
PRG
$1.86B
$640K 0.72%
+22,299
New +$720K
NYT icon
45
New York Times
NYT
$12.3B
$629K 0.71%
+7,509
New +$568K
SND icon
46
Smart Sand
SND
$205M
$628K 0.71%
122,696
+21,707
+21% +$97.8K
VRDN icon
47
Viridian Therapeutics
VRDN
$1.99B
$610K 0.69%
+31,179
New +$926K
TER icon
48
Teradyne
TER
$50.5B
$598K 0.67%
2,016
+980
+95% +$273K
RCKY icon
49
Rocky Brands
RCKY
$309M
$581K 0.65%
15,000
HCI icon
50
HCI Group
HCI
$2.27B
$578K 0.65%
3,737
+2,362
+172% +$387K

Similar funds

Verdad Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, Verdad Advisers held 237 positions worth $88.8M, up 1.7% from $87.4M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Verdad Advisers's Q1 2026 filing shows 133 new, 18 increased, 23 reduced and 58 closed positions. Its largest new stake was Autohome: 121,317 shares worth $2.11M. The largest sale was Citigroup, an estimated $4.03M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

  • Verdad Advisers's largest Q1 2026 buy was Autohome: 121,317 shares worth $2.11M.
  • Verdad Advisers added most to California Resources in Q1 2026, an estimated $867K increase.
  • Verdad Advisers's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $2.79M.
  • Verdad Advisers fully exited Citigroup in Q1 2026, selling an estimated $4.03M.
  • Verdad Advisers's ten largest holdings make up 21% of its $88.8M portfolio in Q1 2026.
  • Verdad Advisers opened 133 new positions and closed 58 in Q1 2026.
  • Verdad Advisers's portfolio value rose 1.7% quarter-over-quarter to $88.8M.

Based on Verdad Advisers's 13F filing for Q1 2026, filed 15 May 2026.